FY4/24
IR PRESENTATION

June 2024

Results Overview© AIN HOLDINGS INC. All Rights Reserved.

1

Consolidated P/L
Net sales increased 11.5% YoY and 2.4% against the plan due to new store openings and growth atexisting stores in both businesses. Ordinary profit increased 25.3% YoY and 10.5% against the plan.
FY4/23
results

FY4/24
revised plan

FY4/24
results

Net sales

358,742

390,263

Gross profit

53,698% of net sales（¥ million）

SG&A expenses% of net sales

Operating profit

YoYchange(%)

Vs
plan (%)

399,824 +41,082

+11.5

+2.4

58,10659,522+5,824

+10.8

+2.4

15.0

14.9

14.9

37,69439,65639,090+1,396

+3.7

(1.4)

10.5

10.2

9.8

16,004

18,45020,432+4,428

+27.7

+10.7

4.5

4.7

5.1

17,064

19,34021,377+4,313

+25.3

+10.5

4.8

5.0

5.3

9,234

10,00011,401+2,167

+23.5

+14.0

2.6

2.6

2.9

262.87284.64324.64+61.77

+23.5

+14.1

% of net sales

Ordinary profit% of net sales
Profit attributable toowners of parent% of net sales
Earnings per share(¥)

YoYchangeFigures in the table are rounded down
© AIN HOLDINGS INC. All Rights Reserved.

2

Dispensing Pharmacy Business (Consolidated)
Net sales increased 11.2% YoY and 2.4% against the plan due to new store openings including M&A,
growth at existing stores, and contribution of stores opened in the previous year. Segment profit
increased 14.3% YoY and 4.5% against the plan.
FY4/23
results

FY4/24
revised plan

Net sales

321,577

349,100

Gross profit

39,779% of net sales（¥ million）

SG&A expenses% of net sales

Operating profit% of net sales

Segment profit% of net sales

Number ofpharmacies

FY4/24
results

YoYchangeYoYchange(%)

Vs
plan (%)

357,571 +35,994

+11.2

+2.4

42,68043,575+3,796

+9.5

+2.1

12.4

12.2

12.2

16,55917,16016,949

+390

+2.4

(1.2)

5.1

4.9

4.7

23,22025,52026,625+3,405

+14.7

+4.3

7.2

7.3

7.4

24,13526,39027,587+3,452

+14.3

+4.5

7.5

7.6

7.7

1,209

1,240

1,231

+22

+1.8

(0.7)

Figures in the table are rounded down

© AIN HOLDINGS INC. All Rights Reserved.

3

Cosmetic and Drug Store Business (Consolidated)
Net sales up 21.1% YoY and 5.5% against the plan due to steady sales growth at both stores openedin the previous year and existing stores. Segment profit increased 155.0% YoY and 28.5% against
the plan.

（¥ million）

Net sales
Gross profit% of net sales

SG&A expenses% of net sales

Operating profit

FY4/23
results

FY4/24
revised plan

YoYchange(%)

Vs
plan (%)

29,500
11,23031,111
11,967+5,426

+21.1

+5.5

+2,273

+23.4

+6.6

8,521

8,830

8,913

+392

+4.6

+0.9

1,172

2,400

3,054

+1,882 +160.6

+27.3

4.6

8.1

9.8

1,214

2,410

3,096

+1,882 +155.0

+28.5

4.7

8.2

10.0

78

82

81

37.7
33.2

% of net sales

Number ofstoresYoYchange25,6859,694% of net sales

Segment profit

FY4/24
results

38.1
29.9

38.5
28.6

+3

+3.8

(1.2)

Figures in the table are rounded down

© AIN HOLDINGS INC. All Rights Reserved.

4

Consolidated B/S
Net cash became ¥41,617 million and shareholders’ equity ratio became 54.3%. We are
maintaining a sound financial structure.
End-FY4/23
AssetsCurrent assets
Cash and deposits

Non-current
assetsGoodwill

Liabilities and Net Assets

98,305

46,796

133,444

46,443

Deferred
assetsTotal assets

Current
liabilities

92,986

Non-current
liabilities

12,218

Short-termborrowings

Long-term
borrowings

3,670

5,021

- Total net assets 126,546
Total liabilities

231,750 and net assets 231,750

Net cash
Shareholders’ equity
ratio(%)

End-FY4/24(¥ million)

37,804
54.6

AssetsLiabilities and Net Assets

Current assets 110,743
Cash and deposits

Non-current
assetsGoodwill

48,611

138,666

44,066

Deferred
assetsTotal assets(¥ million)

Current
liabilities

103,232

Non-current
liabilities

10,765

Short-termborrowings

Long-term
borrowings

3,467

3,227

- Total net assets 135,411
Total liabilities

249,409 and net assets 249,409

Net cash
Shareholders’ equity
ratio(%)

41,61754.3

Figures in the table are rounded down
Net cash = Cash and deposits – Interest-bearing debt
© AIN HOLDINGS INC. All Rights Reserved.

5

Assets
The balance of total assets increased ¥17,659 million from the end of the previous fiscal year
because of increase in inventories and buildings and structures, net, etc., due to the new store
openings.
(¥ million)
Cash and deposits
Accounts receivable - trade
Inventories
Total current assets
Buildings and structures, net
Land
Total property, plant and equipment
Goodwill
Total intangible assets
Investments securities
Deferred tax assets
Leasehold and guarantee deposits
Total investments and other assets
Total non-current assets
Total deferred assets
Total assets

Figures in the table are rounded down

End-FY4/22

59,729
10,11014,790100,765
17,512
8,581
30,63636,352
41,2192,503
5,319
22,78539,840111,696
212,461End-FY4/23

End-FY4/24

46,796
13,24921,58698,305
21,407
10,60239,45946,44352,343
2,720
5,990
24,50741,641
133,444
231,750

48,611
15,852
24,645
110,743
27,122
10,20743,45044,066
51,242
3,345
6,403
25,18643,973
138,666
249,409

Change+1,815+2,603+3,059+12,438+5,715(395)+3,991(2,377)(1,101)
+625
+413
+679
+2,332+5,222+17,659

Change:End-FY4/24 compared with End-FY4/23

Capital expenditures (Property, plant and equipment and intangible assets + Leasehold and guarantee deposits)
totaled ¥15,268 million© AIN HOLDINGS INC. All Rights Reserved.

6

Liabilities and Net Assets
Accounts payable increased ¥6,808 million due to new store openings and M&A. Short-termand long-term borrowings decreased ¥1,997 million.
End-FY4/22

End-FY4/23

50,756
2,643

58,6983,670

65,5063,467+6,808(203)

81,805
5,815

92,986103,232
3,227+10,246(1,794)

Total non-current liabilities

11,645

12,218

10,765(1,453)

Total liabilities

93,450105,204+8,794

Share capital

Total shareholders’ equity

21,89420,50078,661
119,038

Total net assets

119,010

21,89420,50485,963
126,362
126,546

113,998
21,894
20,131
95,257
134,847
135,411+8,865

212,461

231,750

249,409+17,659(¥ million)
Accounts payable – trade
Short-term borrowings
Total current liabilities
Long-term borrowings

Capital surplus
Retained earnings

Total liabilities and net
assetsFigures in the table are rounded down

© AIN HOLDINGS INC. All Rights Reserved.

5,021

End-FY4/24

Change(373)+9,294+8,485

Change:End-FY4/24 compared with End-FY4/23

7

Consolidated C/F
Net cash provided by investing activities became ¥15,748 million due to M&A and new store openings and net cash
provided by operating activities increased ¥23,023 million due to increase in profit before income taxes, etc. Becauseof them, cash and cash equivalents at end of the period increased ¥2,164 million from the previous year. The
company maintained ample cash.

(¥ million)

FY4/23

FY4/24

Change20,26723,023+2,756

15,882

19,080+3,198Depreciation

5,529

6,464

+935

Amortization of goodwill

4,310

4,421

+111

795

(2,202)（2,997)(4,948)(2,929)+2,0191,007(3,883)（4,890)

3,013

6,437

+3,424(22,292)（15,748)+6,544(12,155)（12,519)（364)（14,614)（1,771)+12,843（11,237)（5,110)+6,127（13,262)

2,164+15,426

46,217

48,381+2,164

Net cash provided by operating activities
Profit before income taxes

Decrease (increase) in trade receivables
Decrease (increase) in inventories
Decrease (increase) in accounts receivable other
Increase (decrease) in trade payables
Net cash provided by investing activities
Purchase of property, plant and equipment andintangible assets
Purchase of shares of subsidiaries resulting inchange in scope of consolidation
Net cash provided by financing activities
Net increase (decrease) in cash and cash
equivalents
Cash and cash equivalents at end of the period
Figures in the table are rounded down
© AIN HOLDINGS INC. All Rights Reserved.

8

Business Value Analysis
Shareholders’ equity ratio (%)
Market value equity ratio (%)
PER (times)
EPS (¥)PBR (times)
BPS (¥)ROA (%)ROE (%)EBITDA (¥ million)
EV/EBITDA (times)
Net D/E ratio (times)
Net cash (¥ million)
Shareholders’ value (¥ million)
Market capitalization (¥ million)

FY4/22

56.0

96.6
28.99
201.471.74
3,385.51
3.4
6.0
24,065
6.54(0.43)
51,030208,305
205,143

FY4/23

54.6
85.5
21.46
262.87
1.58
3,599.47
4.2
7.5
25,8436.34(0.30)
37,804
201,720
198,133

FY4/24

54.3
83.8
18.39
324.64
1.56
3,866.55
4.7
8.7
31,3185.44(0.31)
41,617
211,864
208,916

Change(0.3)(1.7)(3.07)+61.77(0.02)+267.08+0.5+1.2+5,475(0.90)(0.01)+3,813+10,144+10,783

Figures in the table are rounded down
Change：FY4/24 compared with FY4/23
Net D/E ratio = Net interest-bearing debt (Interest-bearing debt – Cash and deposits) / Shareholders’ equity
Net cash = Cash and deposits– Interest-bearing debt
Shareholders’ value = EV – Net interest-bearing debt
Market capitalization：Treasury shares is excepted
Share prices used to calculate market capitalization:
End-FY4/22 ¥5,840 (End-Apr, 2022), End-FY4/23 ¥5,640 (End-Apr, 2023), End-FY4/24 ¥5,970 (End-Apr, 2024).
© AIN HOLDINGS INC. All Rights Reserved.

9

FY4/25 Plan (Consolidated)
The group forecasts net sales for the fiscal year ending April 30, 2025 increase 3.8% YoY due to new store
openings of 80 stores for dispensing pharmacy business and 10 stores for cosmetic and drug store business.
Ordinary profit will decrease 13.5% YoY due to increase in costs of human capital and digital transformation
investments.
（¥ million）

FY4/23
results

FY4/24
results

FY4/25plan

YoYchangeYoYchange(%)

Net sales

358,742

399,824

415,000 +15,176+3.8

Gross profit

53,69859,522

59,671+149+0.3

37,69439,09041,871+2,781+7.1

16,004

20,432

17,800(2,632)(12.9)

17,064

21,37718,500(2,877)(13.5)

9,234

11,4019,180(2,221)(19.5)% of net sales

2.6

2.9

2.2

Earnings per
share(¥)

262.87324.64262.33(62.31)(19.2)

60.00

80.00

80.00

-

0.0

% of net sales

SG&A expenses% of net sales

Operating profit% of net sales

Ordinary profit% of net sales

Profit attributable toowners of parent

Annual dividend (¥)

15.0
10.5
4.5
4.8

Figures in the table are rounded down
© AIN HOLDINGS INC. All Rights Reserved.

14.9
9.8

5.1
5.3

14.4
10.1
4.3
4.5

10

Review© AIN HOLDINGS INC. All Rights Reserved.

11

Consolidated (YoY)
Ordinary profit increased ¥4.3 billion YoY due to increase of net sales in dispensing pharmacy
business and cosmetic and drug store business.
Net sales¥358.7 billion

Dispensing
pharmacy¥321.5 billion

Ordinary profit¥399.8 billion +¥41.1 billion+11.5%

Dispensing
pharmacy¥357.5 billion

Cosmetic and drug store Cosmetic and drug store¥25.6 billion¥31.1 billion

Others ¥11.6 billion

Others ¥11.2 billion

FY4/23

FY4/24© AIN HOLDINGS INC. All Rights Reserved.

¥17.0 billion■Dispensing
pharmacy■Dispensing
pharmacy+¥36.0 billion

Dispensing
pharmacy■Cosmetic anddrug store+¥5.5 billion¥24.1 billion■Others¥(0.4) billion¥21.3 billion +¥4.3 billion+25.3%

Dispensing
pharmacy¥27.5 billion+¥3.4billion■Cosmetic anddrug store+¥1.8 billion■ Others¥(0.1) billion

Cosmetic and drug store¥1.2 billion
Others ¥0.1 billion

Cosmetic and drug store¥3.0 billion
Others ¥0.0 billion

Administrative
expense, etc.
¥(8.4) billion

Administrative
expense, etc.
¥(9.2) billion

Administrative
expense, etc.
¥(0.8) billion
Digital transformation
investments¥(0.4) billion
FY4/23
FY4/24
Personnel costs¥(0.4) billion
etc.
Decrease against profit：（）
12

Consolidated (vs Revised Plan)
Ordinary profit increased ¥2.0 billion against the revised plan due to increase in gross profit because thenumber of prescriptions increased in the dispensing pharmacy business, and decrease in SG&A expenses fromthe improvement of operational efficiency in the cosmetic and drug store business.

Net sales¥390.2 billion

Dispensing
pharmacy¥349.1 billion

Ordinary profit¥399.8 billion +¥9.6 billion+2.4%

Dispensing
pharmacy¥357.5 billion■Dispensing
pharmacy+¥8.4 billion■Cosmetic anddrug store+¥1.6 billion¥19.3 billion

Dispensing
pharmacy¥26.3 billion

Cosmetic and drug store Cosmetic and drug store¥29.5 billion¥31.1 billion
Others ¥11.6 billion
Others ¥11.2 billion

FY4/24plan

FY4/24
results

Dispensing
pharmacy¥27.5 billion■Dispensing
pharmacy+¥1.2 billion■Cosmetic anddrug store

Cosmetic and Drug Store¥2.4 billion
Others ¥0.0 billion■ Others¥(0.4) billion¥21.3 billion ＋¥2.0 billion+10.5%

Cosmetic and Drug Store¥3.0 billion+¥0.6 billion

Others ¥0.0 billion

Administrative
expense, etc.
¥(9.4) billion

Administrative
expense, etc.
¥(9.2) billion

FY4/24plan

FY4/24
results

Administrative
expense, etc.
＋¥0.2 billion

Increase against profit：+© AIN HOLDINGS INC. All Rights Reserved.

13

Number of Pharmacies and Stores

Opening■ Plan and Results

Revised Plan

Results

Dispensing Pharmacy

41

40

80

Organic

21

19

20

21

40

6

6

10

47

46

90

10
2

18
3

16

12

21

18

M&A
Cosmetic and drug store
Total
Dispensing Pharmacy
Cosmetic and drug store

ClosureFY4/25

FY4/24

Total

Plan

40

2

■ Transition of dispensing pharmacies
Organic
M&A

EV/EBITDA ratio

ClosedSold
No. of total stores

FY4/17

FY4/18

FY4/19FY4/20FY4/21

FY4/22

FY4/23

FY4/24

27

25

23

14

15

25

27

19

182
5.50
22
2
1,066

11
3.96
41
32
1,029

134
4.88
24
30
1,132

6
3.71
22
42
1,088

14
3.74
18
34
1,065

24
4.13
10
5
1,099

114
6.55
24
7
1,209

21
4.41
13
5
1,231

EV/EBITDA ratio=EV(Purchase price)/EBITDA(Operating profit + Depreciation)© AIN HOLDINGS INC. All Rights Reserved.

14

FY4/25 Plan

© AIN HOLDINGS INC. All Rights Reserved.

15

Transition of dispensing fee revisions
Although the company has been affected by the revision of dispensing fees and changes insocial conditions, it has steadily increased earnings while realizing the role required ofpharmacies and strengthening its management base.
（¥ billion）（¥ billion）

5,000
500

Net sales

Respond to COVID-19
Primary care, home-based healthcare,human capital, and digital transformation investment

Ordinary profit
Premiums for community support
IT Management Division was established

4,000
400

400
40

Net sales

3,000
300

200
20

2,000
200
100
10

1,000
100
0

FY4/16

FY4/17

 Apr. 2016
Revisions todispensing fees
Social conditions

Ordinary Profit

300
30

Basic dispensing
fee at chain
pharmacies
located near thehospitals
decreased© AIN HOLDINGS INC. All Rights Reserved.

FY4/18

FY4/19 Apr. 2018

Basic dispensing fee
at large-scale chain
pharmacies locatednear the hospitals
decreased
Onsite pharmacies
was newly establishedFY4/20FY4/21

 Feb. 2020

Spread of COVID19 infections

FY4/22

FY4/23

 Apr. 2022
Basicdispensing fee
at chain dragstoresdecreased

FY4/24

FY4/25 FY4/26（plan）（forecast）

0 Apr. 2024

Premiums and drug
fees at onsite
pharmacies
decreased

16

Strategy© AIN HOLDINGS INC. All Rights Reserved.

17

Strategy
Expansion of top-line■ Dispensing Pharmacy business strategy■Organic store openings and utilization of M&A■Further strengthening specialist skills of pharmacists andproviding patients-centered pharmacy services■ Cosmetic and drug store business strategy■Organic store openings and utilization of M&A■Creating product lineups and sales displays specialize in cosmetics

Reinforcing the Groupʼs business base
■ Human capital■ Digital transformation investment■ Sustainability management© AIN HOLDINGS INC. All Rights Reserved.

18

Expansion of top-line
FY4/24 Results

1,312

Dispensing
Pharmacies
Cosmetics andDrug stores

FY4/25 Plan

1,231
81

1,384

Dispensing
Pharmacies
Cosmetics andDrug stores

114
18

1,295
89

163
1

156
1

69
7

:Dispensing Pharmacies

146
8

224
2

359
44

：Cosmetic and drug stores© AIN HOLDINGS INC. All Rights Reserved.

19

FY4/25 Plan (Dispensing Pharmacy Business)
The group forecasts net sales increase 3.3% YoY and segment profit decrease 9.2% YoY
due to opening 80 new stores including M&A and closing 16 stores.
FY4/23
results

FY4/24
results

FY4/25plan

Net sales

321,577

357,571369,540 +11,969+3.3

Gross profit

39,77943,57542,390 (1,185)(2.7)

16,55916,94918,080+1,131+6.7

23,22026,62524,310 (2,315)(8.7)

24,13527,58725,040 (2,547)

(9.2)

1,209

1,231

1,295

+5.2

（¥ million）% of net sales

SG&A expenses% of net sales

Operating profit% of net sales

Segment profit% of net sales

Number ofpharmacies

12.4
5.1
7.2
7.5

12.2
4.7
7.4
7.7

YoY
changeYoYchange (%)

11.5
4.9
6.6
6.8

+64

Figures in the table are rounded down
Segment profit is adjusted to ordinary profit shown on the consolidated statements of income© AIN HOLDINGS INC. All Rights Reserved.

20

Expansion of top-line
AINZ & TULPEIn FY4/24 opened

6
7
5
4
3
2
1

storesDUO KOBE(Opened in Nov. 2023)

ecute UENO
（Opened in Dec. 2023)© AIN HOLDINGS INC. All Rights Reserved.

COCONO SUSUKINO（Opened in Nov. 2023)

COCOLIA TAMA CENTER(Opened in June 2023 ）21

Expansion of top-line
AINZ & TULPEIn FY4/25 plan to open

10 店舗

stores

パース掲載

Tokyo A
（Plan to open in Oct. 2024 ）Carrot St. SANCHA(Opened in June 2024)
Tokyo B
（Plan to open in Nov. 2024 ）© AIN HOLDINGS INC. All Rights Reserved.

EQUiA TAKENOTSUKA（Opened in May 2024）

22

Expansion of top-line
Setting priority areas andopening flagship stores
mainly in urban areas

Specialize in cosmetics and otherbeauty products
Cosmetics and other beauty products

Number of prospective store openings

180

Hokkaido
Prospective
store openings

1

1.4%
1.6%
8.8%

Kansaiprospective
store openings

40

Kyushuprospective
store openings

4

Tokai・Chugoku
prospective
store openings

5

12.4%

23.4%

Kanto
prospective
store openings

130

Number of prospective store openings© AIN HOLDINGS INC. All Rights Reserved.

90%■ Cosmetics and otherbeauty products■ Over-the-counter drugs
and sanitary products■ Foods and health foods■ Daily necessities

AINZ & TULPE

88.2%

Generaldrug
stores 28.3%
35.9%

AINZ & TULPE: Results in FY4/24
General drug stores: Monthly Report on the
Current Survey of Commerce（Mar.2024
Ministry of Economy, Trade and Industry）
23

FY4/25 Plan (Cosmetic and Drug Store Business)
The group forecasts net sales increase 6.8% YoY and segment profit increase 9.8% YoY due
to opening 10 new stores and closing 2 stores.

（¥ million）

FY4/23
results

FY4/24
results

FY4/25plan

YoYchangeNet sales

25,685

31,111

33,240+2,129+6.8

Gross profit

9,694

11,967

12,800

+833

+7.0

8,521

8,913

9,400

+487

+5.5

1,172

3,054

3,400

+346

+11.3

1,214

3,096

3,400

+304

+9.8

78

81

89

+8

+9.9

% of net sales

SG&A expenses% of net sales

Operating profit% of net sales

Segment profit% of net sales

Number ofstores

37.7
33.2
4.6
4.7

38.5
28.6
9.8

10.0

YoY
change (%)

38.5
28.3
10.2
10.2

Figures in the table are rounded down
Segment profit is adjusted to ordinary profit shown on the consolidated statement of income© AIN HOLDINGS INC. All Rights Reserved.

24

Human capital
In April 2024, new 532 pharmacists has joined our group. We aim to hire about 600 new
pharmacists in fiscal 2025. As of April 30,2024, the group has 6,478 pharmacists out of
15,114 employees.

（people）

No. of newly hired
students

800

Pharmacists

Medical support staff

600
639
400
660

613

560

543

200
215

240

346

532

600 600

213

0

2020

2021

2022

2023

2024

2025

（year）（plan）© AIN HOLDINGS INC. All Rights Reserved.

25

Digital transformation investment
Along with responding to deregulation of digital prescriptions and online eligibility checks,
etc., the company utilize digital transformation to provide added value that only AIN Groupcan offer and to improve store operating efficiency.
Reinforcethe management base
経営基盤の強化 Operation of internal-facing
call centers using AI
Streamline inquiries regarding
dispensing systems,
merchandising systems, andheadquarters systems by using AI

 Filling out medication history
using AI© AIN HOLDINGS INC. All Rights Reserved.

Respondto deregulation
規制緩和への対応

付加価値の提供
Provideadded value

Digital prescriptions
 電子処方箋への対応

 アイン薬局公式アプリ
Official AIN Pharmacy app
Anytime AIN Pharmacy「いつでもアイン薬局」

 Online pharmaceutical guidance アインズ&トルペ実店舗
Data linkage

Already responded at morethan 1,000 pharmacies

Already responded at all pharmacies

AINZ & TULPE real stores /Official
AINZ & TULPE app /E-commercechannels

26

Sustainability management 1
We have conducted our corporate activities with common sense and ethics in order to realize our groupstatement of “the health and happiness of our customers" through our businesses contributing to people's
health and beauty. Going forward, we will achieve sustainable corporate growth, create social, environmental,
and economic value, and realize sustainable management by changing and acting on our own initiative,
considering our customers and other diverse stakeholders.

1.Contribute to local healthcare

Pharmacies contributing to medical care that "treats
and supports in the entire community”

3.Safety, peace of mind
and trust
Delivering safety, peace ofmind, and trust through daily
operations
Preamble“realize the human rights of all”

2.Provide beauty and happiness
Providing beauty and happiness to enjoy
daily life in today's society

5.Ensure sound management
base

Strengthen a sound management basePreamble“realize the human rights of all”

4.Protect theenvironment and reduce
environmental impact
Contribute to environmental
protection and load reduction

6.Cooperate with local
communities and businesses
Promoting a healthy society andsustainability activities with local
communities and supply chains© AIN HOLDINGS INC. All Rights Reserved.

27

Sustainability management 2
Within our Sustainability Committee, approximately 30 project teams are promoting cross-sectoral
initiatives for each materiality.

Stakeholder engagement
We invited outside experts
and hold a dialogue. We
received objective
evaluations and advice on
our sustainability activities,
which we reflect them in our
activities.

Supply chain management
We held a briefing session andconducted a survey forsuppliers about CSR
Procurement. We arestrengthening supply chain
management for realizing asustainable society.

External evaluations
Diversity ＆ Inclusion
Certified
Platinum Kurumin

Certified Health
Outstanding Organizations
Recognition Program for2024 (White 500)

© AIN HOLDINGS INC. All Rights Reserved.

Climate change

ESG Ratings

Receiveda B score

Received
an A ratingLGBT friendly
companies in Sapporo

28

FY4/25 Plan (Consolidated)
The group forecasts net sales for the fiscal year ending April 30, 2025 increase 3.8% YoY due to new store
openings of 80 stores for dispensing pharmacy business and 10 stores for cosmetic and drug store business.
Ordinary profit will decrease 13.5% YoY due to increase in costs of human capital and digital transformation
investments.
（¥ million）

FY4/23
results

FY4/24
results

FY4/25plan

YoYchangeYoYchange(%)

Net sales

358,742

399,824

415,000 +15,176+3.8

Gross profit

53,69859,522

59,671+149+0.3

37,69439,09041,871+2,781+7.1

16,004

20,432

17,800(2,632)(12.9)

17,064

21,37718,500(2,877)(13.5)

9,234

11,4019,180(2,221)(19.5)% of net sales

2.6

2.9

2.2

Earnings per
share(¥)

262.87324.64262.33(62.31)(19.2)

60.00

80.00

80.00

-

0.0

% of net sales

SG&A expenses% of net sales

Operating profit% of net sales

Ordinary profit% of net sales

Profit attributable toowners of parent

Annual dividend (¥)

15.0
10.5
4.5
4.8

Figures in the table are rounded down
© AIN HOLDINGS INC. All Rights Reserved.

14.9
9.8

5.1
5.3

14.4
10.1
4.3
4.5

29

Inquiries related to this presentation should be addressed to

AIN HOLDINGS INC.
Corporate Planning Division
TEL(81)11-814-0010
FAX(81)11-814-5550
https://www.ainj.co.jp/corporate/
This document may not be reproduced or distributed to any third party without
prior approval of AIN HOLDINGS INC. This document has been prepared for
information purpose only and does not form part of a solicitation to sell orpurchase any securities. Information contained herein may be changed orrevised without prior notice. This document may contain forecastingstatements as to future results of operations. No forecast statement can be
guaranteed and actual results of operations may differ from those projected.

© AIN HOLDINGS INC. All Rights Reserved.

30